1. Home
  2. CLDX vs POET Comparison

CLDX vs POET Comparison

Compare CLDX & POET Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Celldex Therapeutics Inc.

CLDX

Celldex Therapeutics Inc.

HOLD

Current Price

$33.93

Market Cap

2.6B

Sector

Health Care

ML Signal

HOLD

Logo POET Technologies Inc.

POET

POET Technologies Inc.

HOLD

Current Price

$9.42

Market Cap

1.9B

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
CLDX
POET
Founded
N/A
1972
Country
United States
Canada
Employees
N/A
N/A
Industry
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Semiconductors
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
2.6B
1.9B
IPO Year
1995
2008

Fundamental Metrics

Financial Performance
Metric
CLDX
POET
Price
$33.93
$9.42
Analyst Decision
Strong Buy
Analyst Count
10
0
Target Price
$46.60
N/A
AVG Volume (30 Days)
913.4K
29.3M
Earning Date
05-04-2026
08-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$12,743,000.00
N/A
Revenue This Year
$111.39
$848.96
Revenue Next Year
$235.85
$700.00
P/E Ratio
N/A
N/A
Revenue Growth
87.78
N/A
52 Week Low
$19.52
$3.87
52 Week High
$35.83
$20.65

Technical Indicators

Market Signals
Indicator
CLDX
POET
Relative Strength Index (RSI) 62.80 39.33
Support Level $28.51 $5.31
Resistance Level $35.10 $15.51
Average True Range (ATR) 1.23 1.37
MACD 0.43 -0.42
Stochastic Oscillator 78.89 1.12

Price Performance

Historical Comparison
CLDX
POET

About CLDX Celldex Therapeutics Inc.

Celldex Therapeutics Inc is a biopharmaceutical firm focused on mast cell biology and the development of therapeutic antibodies. Its pipeline includes monoclonal and bispecific antibodies aimed at treating severe inflammatory, allergic, autoimmune, and other mast cell-mediated diseases. The company operates in a single operating and reportable segment in the business of development, manufacturing and commercialization of novel therapeutics for human health care.

About POET POET Technologies Inc.

POET Technologies Inc is a design and development company offering high-speed optical engines, light source products, and custom optical modules to the artificial intelligence systems market and hyperscale data centers. Its integration solutions are based on the POET Optical Interposer, a novel, patented platform that allows the seamless integration of electronic and photonic devices into a single chip using wafer-level semiconductor manufacturing techniques. POET's Optical Interposer platform also solves device integration challenges across a broad range of communication, computing, and sensing applications. The company operates geographically in the United States, Canada, Singapore and China.

Share on Social Networks: